QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium

Subramanian Kannan1, Murali M B Venkataraman2, Salila S Chandorkar3

  • 1Department of Endocrinology Diabetes and Metabolism, Narayana Hrudayalaya, Bengaluru, Karnataka, India.

Insights

Diabetes patients with high QRISK 3® or ASCVD scores may need further evaluation for cardiovascular disease risk using CT coronary artery calcium scoring. These scores help identify individuals needing closer monitoring for sub-clinical atherosclerosis.

Area of Science:

  • Cardiology
  • Diabetology
  • Radiology

Background:

  • Diabetes mellitus is a significant independent risk factor for developing asymptomatic cardiovascular disease (CVD).
  • Risk assessment scores like QRISK 3® and ASCVD predict 10-year CVD risk.
  • Coronary artery calcium scoring (CACS) via CT identifies sub-clinical atherosclerosis.

Purpose of the Study:

  • To investigate the correlation between QRISK 3® and ASCVD risk scores and CACS in diabetic patients.
  • To determine predictive cut-off values for QRISK 3® and ASCVD scores indicating moderate or accentuated CACS (≥100).

Main Methods:

  • Prospective study of outpatients with diabetes and no prior coronary artery disease (CAD) or symptoms.
  • Calculation of QRISK 3® and ASCVD risk scores.
  • Performance of 256-slice cardiac CT to determine CACS using the Agatston method.

Main Results:

  • A statistically significant positive correlation was observed between QRISK 3®/ASCVD scores and CACS (r=0.28, P=0.004/0.007).
  • A QRISK® score >23 predicted CACS >100 with 85% sensitivity.
  • An ASCVD score >10 predicted CACS >100 with 90% sensitivity.

Conclusions:

  • QRISK 3® and ASCVD scores are valuable tools for triaging diabetic patients for further CVD risk assessment.
  • CACS evaluation is recommended for diabetic patients with elevated QRISK 3® or ASCVD scores to identify sub-clinical atherosclerosis.
Abstract